Stephens initiated coverage on shares of Itron (NASDAQ:ITRI) in a report published on Monday, BenzingaRatingsTable reports. The firm issued an equal weight rating and a $64.00 price target on the scientific and technical instruments company’s stock.

A number of other analysts also recently commented on the stock. Robert W. Baird upgraded shares of Duluth from a neutral rating to an outperform rating and set a $22.00 target price on the stock in a report on Tuesday, May 7th. BidaskClub downgraded shares of Zebra Technologies from a buy rating to a hold rating in a research report on Wednesday, May 8th. Citigroup set a $210.00 target price on shares of Constellation Brands and gave the stock a hold rating in a research report on Monday, July 1st. Zacks Investment Research raised shares of Gerdau from a sell rating to a hold rating in a research report on Monday, May 13th. Finally, Oppenheimer lifted their target price on shares of Itron from $60.00 to $68.00 and gave the stock an outperform rating in a research report on Tuesday, May 7th. Four investment analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. The stock presently has a consensus rating of Buy and a consensus price target of $68.70.

Shares of ITRI stock traded down $0.87 during midday trading on Monday, reaching $60.59. 3,242 shares of the company were exchanged, compared to its average volume of 326,693. Itron has a 12 month low of $44.35 and a 12 month high of $66.95. The stock has a market capitalization of $2.42 billion, a P/E ratio of 22.89, a P/E/G ratio of 0.95 and a beta of 1.23. The business has a 50 day simple moving average of $59.99. The company has a debt-to-equity ratio of 1.43, a quick ratio of 1.07 and a current ratio of 1.40.

Itron (NASDAQ:ITRI) last released its earnings results on Monday, May 6th. The scientific and technical instruments company reported $0.70 EPS for the quarter, topping analysts’ consensus estimates of $0.43 by $0.27. Itron had a net margin of 1.87% and a return on equity of 17.97%. The business had revenue of $614.58 million for the quarter, compared to the consensus estimate of $591.88 million. During the same period in the previous year, the firm earned $0.13 EPS. The business’s revenue for the quarter was up 1.2% on a year-over-year basis. Equities research analysts predict that Itron will post 2.63 EPS for the current year.

In related news, insider Philip Mezey sold 31,205 shares of the business’s stock in a transaction that occurred on Tuesday, May 7th. The shares were sold at an average price of $59.07, for a total transaction of $1,843,279.35. Following the transaction, the insider now directly owns 109,185 shares of the company’s stock, valued at $6,449,557.95. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, major shareholder Scopia Capital Management Lp sold 55,086 shares of the business’s stock in a transaction that occurred on Wednesday, May 22nd. The shares were sold at an average price of $57.45, for a total transaction of $3,164,690.70. The disclosure for this sale can be found here. Insiders have sold 487,310 shares of company stock worth $26,457,518 over the last ninety days. 2.35% of the stock is currently owned by insiders.

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. FMR LLC increased its holdings in Itron by 3.1% in the 1st quarter. FMR LLC now owns 253,752 shares of the scientific and technical instruments company’s stock valued at $11,837,000 after buying an additional 7,614 shares during the period. Clearbridge Investments LLC increased its holdings in Itron by 13.6% in the 1st quarter. Clearbridge Investments LLC now owns 441,200 shares of the scientific and technical instruments company’s stock valued at $20,582,000 after buying an additional 52,656 shares during the period. Jacobs Levy Equity Management Inc. increased its holdings in Itron by 14.7% in the 1st quarter. Jacobs Levy Equity Management Inc. now owns 203,434 shares of the scientific and technical instruments company’s stock valued at $9,490,000 after buying an additional 26,120 shares during the period. Neuberger Berman Group LLC increased its holdings in Itron by 48.6% in the 1st quarter. Neuberger Berman Group LLC now owns 1,159,467 shares of the scientific and technical instruments company’s stock valued at $54,087,000 after buying an additional 378,967 shares during the period. Finally, Rockefeller Capital Management L.P. increased its holdings in Itron by 10.6% in the 1st quarter. Rockefeller Capital Management L.P. now owns 22,648 shares of the scientific and technical instruments company’s stock valued at $1,057,000 after buying an additional 2,172 shares during the period. 97.56% of the stock is currently owned by hedge funds and other institutional investors.

Itron Company Profile

Itron, Inc, a technology and service company, provides end-to-end solutions that measures, manages, and analyzes energy and water use worldwide. The company operates through three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing.

Read More: What is a Candlestick Chart?

Analyst Recommendations for Itron (NASDAQ:ITRI)

Receive News & Ratings for Itron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Itron and related companies with MarketBeat.com's FREE daily email newsletter.